ProPhase Labs closes public offering of 4.8M shares at $0.72, raising ~$3.45M gross

ProPhase Labs, Inc.

Offering of 4,795,500 shares at $0.72 per share; gross proceeds $3.45M, net proceeds ~$3M.
Underwriters' over-allotment option fully exercised; ThinkEquity acted as sole book-runner.
Net proceeds to be used for working capital, general corporate purposes, and potential acquisitions.
Directors/executives subject to 120-day lock-up; 5%+ holders subject to 90-day lock-up.
Representative warrants issued to purchase up to 5% of shares at $0.90 per share, exercisable after 180 days.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.